Correction: Screening strategies and laboratory assays to support Plasmodium falciparum histidine-rich protein deletion surveillance: where we are and what is needed.

Beshir, Khalid B; Parr, Jonathan B; Cunningham, Jane; Cheng, Qin; Rogier, Eric

Beshir, Khalid B; Parr, Jonathan B; Cunningham, Jane; Cheng, Qin; Rogier, Eric.

Afiliação

Beshir KB; Faculty of Infectious Diseases, London School of Hygiene and Tropical Diseases, Keppel Street, London, WC1E 7HT, UK.
Parr JB; Division of Infectious Diseases and Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
Cunningham J; Global Malaria Programme, World Health Organization, Geneva, Switzerland.
Cheng Q; Drug Resistance and Diagnostics, Australian Defence Force Malaria and Infectious Disease Institute, Brisbane, Australia.
Rogier E; QIMR Berghofer Medical Research Institute, Brisbane, Australia.

Malar J ; 21(1): 266, 2022 Sep 14.

Article em En | MEDLINE | ID: mdl-36104721

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Screening_studies Idioma: En Revista: Malar J Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google